{
    "organizations": [],
    "uuid": "e5c2a5b70e71f916c29d6e40edac0a35f259b283",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-suven-life-sciences-says-fda-obser/brief-suven-life-sciences-says-fda-observed-some-procedures-are-deficient-during-medak-unit-inspection-idUSFWN1S10XY",
    "ord_in_thread": 0,
    "title": "BRIEF-Suven Life Sciences Says FDA Observed Some Procedures Are Deficient During Medak Unit Inspection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Suven Life Sciences Ltd:\n* SUVEN LIFE SCIENCES - FDA DURING INSPECTION OF PASHAMYLARAM, MEDAK UNIT OBSERVED THERE ARE PROCEDURES FOLLOWED ON CERTAIN ASPECTS WHICH ARE DEFICIENT\n* SAYS CO REVISED STANDARD OPERATING PROCEDURES AS CORRECTIVE ACTION Source text - bit.ly/2HW47sz Further company coverage:\n ",
    "published": "2018-04-24T20:32:00.000+03:00",
    "crawled": "2018-04-25T14:39:16.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "suven",
        "life",
        "science",
        "ltd",
        "suven",
        "life",
        "science",
        "fda",
        "inspection",
        "pashamylaram",
        "medak",
        "unit",
        "observed",
        "procedure",
        "followed",
        "certain",
        "aspect",
        "deficient",
        "say",
        "co",
        "revised",
        "standard",
        "operating",
        "procedure",
        "corrective",
        "action",
        "source",
        "text",
        "company",
        "coverage"
    ]
}